Neural Analytics, Inc., a company that builds robotics focused on the health monitoring of the human brain received $22 million in series C financing.
“Over the past six years, we have worked very hard to develop and validate new technologies into impactful products. Though the culmination of years of our work into US FDA clearance & European CE mark was a meaningful milestone in 2018, it was only the start of our journey. With this financing Neural Analytics will be able to launch the Lucid Robotic System into clinical environments where it will have the greatest impact on patient outcomes,” said Leo Petrossian, Ph.D., Co-Founder and Chief Executive Officer of Neural Analytics.
Read More: The Artificial Intelligence Week
The company’s primary offering named the Lucid Robotic System, is a seamless integration between the Lucid™ M1 Transcranial Doppler (TCD) System and the NeuralBot™ System. The finished product is an autonomous system that has the capability to precisely monitor blood flow information for the brain. The futuristic system goes far behind the initial neurovascular diagnoses and can be leveraged across patient care in spheres such as –
- Bubble study in the identification of right-to-left shunts
- Monitoring for cerebral blood flow velocities in real time
- Emboli monitoring
“We are honored to deepen our partnership with Neural Analytics. Over the past year, the company has gained both FDA and EU CE Mark clearance for their revolutionary platform, which harnesses machine learning and robotics to accurately and quickly identify critical neurological conditions. We are confident that the company will play a central role in shaping the future of data-driven diagnostics and bringing new technologies to healthcare professionals to better care for their patients,” said Nick Grouf, Managing Partner at Alpha Edison.
The Series C round was financed by Alpha Edison and the Lucid Robotic system is available only at a few selected hospitals across the United States of America. However, the company is rapidly commercializing.